contract molecule co-development

Capra builds and operates modular biomanufacturing facilities to produce high-value chemicals domestically and on demand. Its Sterling, Virginia facility has a 10,000 ft² footprint and 30,000 L nameplate reactor volume. The company sells into pharmaceuticals, personal care, defense, and industrial markets, and partners with corporate strategic partners, off-takers, and formulators.

Read more

bioproductionfeasibility reviewmodular biomanufacturingScale up